Sofosbuvir for the Treatment of COVID-19 Patients: Is It a Promising Therapeutic Medicine for the Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2?

Letter to the Editor

Guardado en:

Detalles Bibliográficos
Autores principales:	Shahnaz Sali, Shiva Shabani, Soheil Tavakolpour
Formato:	article
Lenguaje:	EN
Publicado:	Hamadan University of Medical Sciences 2020
Materias:	not applicable Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/03a15f9329434da68a7648b87123c547
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:03a15f9329434da68a7648b87123c547
record_format	dspace
spelling	oai:doaj.org-article:03a15f9329434da68a7648b87123c5472021-11-23T09:25:30ZSofosbuvir for the Treatment of COVID-19 Patients: Is It a Promising Therapeutic Medicine for the Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2?10.34172/ajmb.2020.192345-4113https://doaj.org/article/03a15f9329434da68a7648b87123c5472020-12-01T00:00:00Zhttp://ajmb.umsha.ac.ir/PDF/ajmb-8-133.pdfhttps://doaj.org/toc/2345-4113Letter to the EditorShahnaz SaliShiva ShabaniSoheil TavakolpourHamadan University of Medical Sciencesarticlenot applicableMedical technologyR855-855.5ENAvicenna Journal of Medical Biochemistry, Vol 8, Iss 2, Pp 133-135 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	not applicable Medical technology R855-855.5
spellingShingle	not applicable Medical technology R855-855.5 Shahnaz Sali Shiva Shabani Soheil Tavakolpour Sofosbuvir for the Treatment of COVID-19 Patients: Is It a Promising Therapeutic Medicine for the Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2?
description	Letter to the Editor
format	article
author	Shahnaz Sali Shiva Shabani Soheil Tavakolpour
author_facet	Shahnaz Sali Shiva Shabani Soheil Tavakolpour
author_sort	Shahnaz Sali
title	Sofosbuvir for the Treatment of COVID-19 Patients: Is It a Promising Therapeutic Medicine for the Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2?
title_short	Sofosbuvir for the Treatment of COVID-19 Patients: Is It a Promising Therapeutic Medicine for the Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2?
title_full	Sofosbuvir for the Treatment of COVID-19 Patients: Is It a Promising Therapeutic Medicine for the Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2?
title_fullStr	Sofosbuvir for the Treatment of COVID-19 Patients: Is It a Promising Therapeutic Medicine for the Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2?
title_full_unstemmed	Sofosbuvir for the Treatment of COVID-19 Patients: Is It a Promising Therapeutic Medicine for the Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2?
title_sort	sofosbuvir for the treatment of covid-19 patients: is it a promising therapeutic medicine for the inhibition of severe acute respiratory syndrome coronavirus 2?
publisher	Hamadan University of Medical Sciences
publishDate	2020
url	https://doaj.org/article/03a15f9329434da68a7648b87123c547
work_keys_str_mv	AT shahnazsali sofosbuvirforthetreatmentofcovid19patientsisitapromisingtherapeuticmedicinefortheinhibitionofsevereacuterespiratorysyndromecoronavirus2 AT shivashabani sofosbuvirforthetreatmentofcovid19patientsisitapromisingtherapeuticmedicinefortheinhibitionofsevereacuterespiratorysyndromecoronavirus2 AT soheiltavakolpour sofosbuvirforthetreatmentofcovid19patientsisitapromisingtherapeuticmedicinefortheinhibitionofsevereacuterespiratorysyndromecoronavirus2
_version_	1718416803284123648

Sofosbuvir for the Treatment of COVID-19 Patients: Is It a Promising Therapeutic Medicine for the Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2?

Ejemplares similares